The AI Already Inside Your Clinic: Why Private Healthcare's Real Risk Is What Leadership Cannot See

Written By Alexzarn McKenzie

A medical secretary has forty letters to get out. She pastes a rough clinical summary into a free AI chatbot on her phone, asks it to tidy the prose, and copies the polished paragraph back into the patient's letter. It takes ninety seconds and saves her twenty minutes. Nobody asked her to do it. Nobody told her not to. And nobody in the building could later prove it happened.

‍ ‍

This is not a story about reckless staff or rogue technology. It is a story about visibility. Across private healthcare, artificial intel often before leadership has decided anything at all. The uncomfortable question for owners and directors is no longer "Are we using AI?" It is "Could we prove where AI is already touching this organisation, by whom, and under whose authority?"

‍ ‍

For most, the honest answer is no. And in a sector built on sensitive data, patient trust and regulatory scrutiny, that gap between what is happening and what can be evidenced is where the real risk sits.

‍ ‍

The quiet spread

‍ ‍

The evidence that informal AI use is already widespread is not speculative. Netskope Threat Labs, in its annual healthcare threat report, found that regulated data patient records and medical information accounted for 89% of all data-policy violations that occurred in the context of generative-AI use, and that a substantial share of healthcare workers were still routing work through personal AI accounts their employer could not see. In plain terms: staff are pasting sensitive information into tools their organisation does not control, cannot monitor, and has not approved.

‍ ‍

NHS England has taken the phenomenon seriously enough to publish formal guidance, on 27 April 2025, on AI-enabled "ambient scribing" tools systems that listen to a consultation and draft the notes or letter automatically. On 9 June 2025 its National Chief Clinical Information Officer went further, issuing a "Priority Notification: Ensuring Safe and Assured Adoption of AI Scribe Technology," warning organisations not to deploy non-compliant tools after clinicians began adopting them ahead of any national framework. The private sector rarely gets the same central steer, but it uses the same tools, the same suppliers and the same overstretched staff.

‍ ‍

The point is not that any of this is inherently wrong. Used well, with review and oversight, these tools are genuinely useful. The point is that much of it is happening informally, invisibly, and without a record.

‍ ‍

Why private healthcare is more exposed

‍ ‍

Every organisation faces some version of this. Private healthcare faces a sharper version, for three reasons.

‍ ‍

First, the data. Health information is "special category" data under UK GDPR, carrying the highest level of protection and the strictest conditions for processing. A marketing firm leaking email addresses is a problem; a clinic leaking diagnoses, images or mental-health records is a different order of harm.

‍ ‍

Second, trust. Patients pay for discretion as much as treatment. When that is broken, the damage is immediate and personal. In 2024 the London Clinic one of the country's best-known private hospitals reported a breach after staff allegedly tried to access the Princess of Wales's records. On 17 June 2026 the Information Commissioner's Office concluded its criminal investigation by issuing a former healthcare professional a formal caution for an offence under section 170(5) of the Data Protection Act 2018; the ICO said the conduct involved "the deliberate misuse of highly sensitive personal information and an offer to disclose it for financial gain, representing a clear breach of trust." The hospital stressed there were no regulatory breaches on its part. But the reputational lesson is stark: the institution's name, not the individual's, led every headline. Information Commissioner's OfficeITV News

‍ ‍

Third, regulatory expectation. The Care Quality Commission's Regulation 17 ("good governance") requires providers to maintain "accurate, complete and detailed records" and to operate systems that assess, monitor and mitigate risk. Crucially, CQC does not assess whether a policy exists; it assesses whether the governance the policy describes is actually happening and whether the records can prove it. A policy stating "staff must not use unapproved AI" means little if leadership cannot demonstrate whether they do.

‍ ‍

The assurance that isn't

‍ ‍

Here is the distinction that should keep clinic directors awake, because it is the one most often missed.

‍ ‍

There is a world of difference between a supplier telling you your data is secure and a supplier telling you it does not use AI. These are two entirely different assurances, and clinics routinely treat them as one.

‍ ‍

Your data is secure" is a statement about data protection: encryption, access controls, GDPR compliance. "We don't use AI" is a statement about how your data is processed and by what. A supplier can be entirely truthful on the first and silent or simply out of date on the second. A platform can be fully GDPR-compliant and still have quietly added an AI summarisation feature, or begun routing data through a third-party AI model, that nobody at the clinic ever approved.

‍ ‍

This is not hypothetical. DataGrail's Privacy and AI Trends Report 2026, released on 27 May 2026, analysed 2,400 business software providers and found that 63.6% of vendors prominently advertising AI capabilities did not disclose a third-party AI subprocessor in their legal documentation. Software companies are becoming AI companies through routine updates, often faster than their own contracts are rewritten. The vendor you carried out due diligence on last year may not be the vendor operating inside your systems today. VentureBeat

‍ ‍

So when a clinic asks a supplier "Is our data safe?" and receives a reassuring yes, it has answered only half the question. It has not asked where the data goes, who can access it, whether it is used to train a model, whether subcontractors are involved, or whether an AI feature has been switched on since the contract was signed. As the governance world increasingly puts it: you cannot govern what you cannot see. Vendor trust is not a control. Captain Compliance

‍ ‍

Policies are not evidence

‍ ‍

Most established private providers already have the right documents. Data protection policies, safeguarding procedures, complaints processes, clinical governance frameworks. This is precisely why AI is such a peculiar risk: it slips beneath the paperwork. It sits in staff behaviour, in a software update, in a call-summary tool, in a booking system's new "smart" feature, in the transcription app a clinician downloaded to save time.

‍ ‍

The board may sincerely believe AI is not used formally. That belief can be true and irrelevant at the same time, because informal and embedded use does not announce itself. The gap is not between good clinics and bad clinics. It is between what an organisation does and what it can show.

‍ ‍

When the questions come

‍ ‍

The consequences of poor visibility rarely arrive as a dramatic enforcement action. They arrive as a question that cannot be answered.

‍ ‍

Consider the indemnity dimension, which for many private operators is a more immediate worry than the regulator. Medical defence organisations have been unambiguous. The Medical Protection Society advises that "clinicians remain responsible for the decisions they make when diagnosing and treating patients when using AI tools," and critically that it "would not normally provide indemnity for issues relating to the failure of AI software itself." The MDDUS puts it plainly: clinicians "must ensure any AI-generated content is customised and critically reviewed," and "the clinician remains accountable, for better or worse." NHS England's own guidance states that the user of an ambient scribe "is responsible and accountable for the accuracy of information which is added to patient or service user records." Medical Protection Society + 3

‍ ‍

Now imagine an indemnity insurer, reviewing a claim, asks a simple question: how was this AI-assisted letter or note reviewed and approved before it entered the record? If the honest answer is "we didn't know AI was involved," the organisation is not merely embarrassed. It may be exposed. Insurance brokers have begun flagging a further danger the gap between policies. As the broker Howden has noted, "most medical liability policies exclude anything to do with a system failure, while the tech and cyber policy will exclude any bodily injury," meaning an AI-related incident can fall into a crevice between two policies that each assume the other responds. Underwriters, Howden observes, increasingly look for "audit trails and documentation" and "human-in-the-loop controls" before committing capacity. Howden InsuranceHowden Insurance

‍ ‍

The supplier dimension carries its own hard lesson. In March 2025 the ICO fined Advanced Computer Software Group £3.07m its first-ever fine against a data processor rather than a data controller after a 2022 ransomware attack exposed the personal data of 79,404 people, including information on how to enter the homes of 890 people receiving care at home. The attackers got in through an account without multi-factor authentication. The June 2024 ransomware attack on the pathology provider Synnovis, which disrupted London hospitals for months and was linked to a patient's death, made the same point in a different register: when your supplier fails, the consequences and the questions land on you.

‍ ‍

A safeguarding problem, not just a privacy one

‍ ‍

For providers in mental health, learning disability and supported living, the stakes shift again and the language matters. Here the issue is not only patient trust or data protection; it is safeguarding evidence. CQC assessments in these settings look for Mental Capacity Act records, Deprivation of Liberty Safeguards documentation, safeguarding logs, and clear accountability for decisions about vulnerable adults.

‍ ‍

If a support worker uses an AI tool to summarise an incident involving a resident who lacks capacity, and that summary quietly omits or reshapes a detail, the organisation faces a distinct danger: its safeguarding record the very evidence meant to protect a vulnerable person and the provider alike may have been shaped by a tool nobody sanctioned and no one can audit. In a sector where the record is the safeguard, an unseen, unrecorded AI step is not a productivity footnote. It is a hole in the evidence chain.

‍ ‍

What responsible visibility looks like

‍ ‍

None of this argues against AI. It argues for being able to see it. The practical starting point is not a new policy but a set of plain questions leadership should be able to answer:

‍ ‍

  • Where is AI actually being used across the organisation admin, letters, notes, triage support, booking, image handling, transcription?

  • Which staff use which tools, and with what data?

  • Which of our suppliers use AI, and have any added AI features since we contracted them?

  • Where is data stored, who can access it, and is any patient information used to train a model?

  • Are subcontractors involved? Is there a retention policy, an approval process, an audit trail?

  • Who owns accountability for AI use and could we evidence that oversight tomorrow if asked?

‍ ‍

The organisations that will weather the coming scrutiny are not the ones with the thickest binder of policies. They are the ones that can produce a clear, current map of where AI touches their operations and show who authorised it.

‍ ‍

In private healthcare, trust is not protected by assuming systems are safe. It is protected by being able to show how they are used, who controls them, and what evidence exists when the questions are asked by a patient, a regulator, an insurer or the press.

‍ ‍

This article raises questions for private healthcare leaders to consider. It is not legal, compliance or insurance advice, and it does not accuse any provider or supplier of wrongdoing.

‍ ‍

NextGen Governance helps private healthcare organisations identify, map and govern AI use before hidden activity becomes operational, data or repetitional risk.





Learn more

Source list

‍ ‍

Alexzarn McKenzie
Next

Your Software Provider Says Patient Data Is Secure. What Questions Have You Never Asked?